The annual SciBite Seminar targeted senior research management who are actively considering AI-type technologies. Matador's dedicated SciBite sales team worked with our shared marketing services to develop a list of likely candidates. Recruitment for the event was of course aided by the fact that Dr Saito, Principal Research Scientist of Mitsubishi Tanabe Pharma kindly agreed to participate in the round table discussion.

Rob Greenwood, SciBite CEO shared his vision for his business which the Matador team followed with updates of case studies presented at SciBite's global User Group Meeting earlier in the year. The highlight was probably a panel discussion including Dr Saito, on the “Role of SciBite in AI drug discovery”.

We followed up with a cocktail party where attendees were able to interact, take the opportunity to exchange information and experiences about overcoming obstacles with our solutions. after almost three years of being unable to attend such functions, it was great to see that most attendees were extremely enthusiastic.

Stephen Ueki, Matador Director of Research Products wrote :

It was quite a challenge to host such event even after 2 years of the COVID-19 pandemic break out, as some companies still restrict employee participation for in-person events. However, the customers really appreciated networking, and the opportunity to share their experiences with SciBite